Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2014

01-11-2014 | Original Article

Effect of Omeprazole Dose, Nonsteroidal Anti-inflammatory Agents, and Smoking on Repair Mechanisms in Acute Peptic Ulcer Bleeding

Authors: Tuomo Rantanen, Marianne Udd, Teemu Honkanen, Pekka Miettinen, Vesa Kärjä, Lassi Rantanen, Risto Julkunen, Harri Mustonen, Timo Paavonen, Niku Oksala

Published in: Digestive Diseases and Sciences | Issue 11/2014

Login to get access

Abstract

Background

Peptic ulcer bleeding (PUB) is a major cause of upper gastrointestinal bleeding. The effect of omeprazole on mucosal repair is unknown.

Aims

We studied the effect of omeprazole, nonsteroidal anti-inflammatory agents, and smoking on PUB.

Methods

There were 43 PUB patients who received regular or high dose of omeprazole for 72 h. Biopsies from antrum and corpus were taken before and after treatment. Biopsy samples from 20 celiac disease patients worked as controls. The expression of Ki-67, Bcl-2, COX-2, Hsp27, and Hsp70 was analyzed from patients and controls.

Results

Bcl-2 expression in PUB patients was lower than in controls. However, Bcl-2 increased significantly from 5.0 (SD 4.5) to 9.1 % (SD 6.7), p = 0.0004, in the antrum after omeprazole. In univariate analysis, a high omeprazole dose caused a more profound increase in Ki-67 expression in the corpus: 35.3 % (SD 54.8) than a regular dose: −10.1 % (SD 40.6), p = 0.022. In multivariate analysis, Ki-67 decreased significantly in the corpus between the pre- and posttreatment period (p = 0.011), while a high omeprazole dose (p = 0.0265), the use of NSAIDs (p = 0.0208), and smoking (p = 0.0296) significantly increased Ki-67 expression. Bcl-2 in the corpus increased significantly (p = 0.0003) after treatment.

Conclusions

Our findings suggest that Bcl-2 may be an important factor in the pathogenesis of a peptic ulcer and PUB. In addition, high-dose omeprazole increased the expression of Ki-67, which may enhance the healing process of a peptic ulcer.
Literature
1.
go back to reference Laine L, Yang H, Chang SC, Datto C. Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol. 2012;107:1190–1195.PubMedCrossRef Laine L, Yang H, Chang SC, Datto C. Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol. 2012;107:1190–1195.PubMedCrossRef
2.
go back to reference Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993–2002: a population-based cohort study. Am J Gastroenterol. 2006;101:945–953.PubMedCrossRef Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993–2002: a population-based cohort study. Am J Gastroenterol. 2006;101:945–953.PubMedCrossRef
3.
go back to reference Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen GM. Endoscopic therapy for peptic ulcer hemorrhage: practice variations in a multi-center U.S. consortium. Dig Dis Sci. 2010;55:2568–2576.PubMedCrossRefPubMedCentral Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen GM. Endoscopic therapy for peptic ulcer hemorrhage: practice variations in a multi-center U.S. consortium. Dig Dis Sci. 2010;55:2568–2576.PubMedCrossRefPubMedCentral
4.
go back to reference Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997;336:1054–1058.PubMedCrossRef Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997;336:1054–1058.PubMedCrossRef
5.
go back to reference Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74:38–43.PubMed Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74:38–43.PubMed
6.
go back to reference Udd M, Toyry J, Miettinen P, Vanninen E, Mustonen H, Julkunen R. The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring. Eur J Gastroenterol Hepatol. 2005;17:1351–1356.PubMedCrossRef Udd M, Toyry J, Miettinen P, Vanninen E, Mustonen H, Julkunen R. The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring. Eur J Gastroenterol Hepatol. 2005;17:1351–1356.PubMedCrossRef
7.
go back to reference Udd M, Miettinen P, Palmu A, et al. Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study. Scand J Gastroenterol. 2007;42:1395–1403.PubMedCrossRef Udd M, Miettinen P, Palmu A, et al. Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study. Scand J Gastroenterol. 2007;42:1395–1403.PubMedCrossRef
8.
go back to reference Udd M, Miettinen P, Palmu A, Julkunen R. Effect of short-term treatment with regular or high doses of omeprazole on the detection of helicobacter pylori in bleeding peptic ulcer patients. Scand J Gastroenterol. 2003;38:588–593.PubMedCrossRef Udd M, Miettinen P, Palmu A, Julkunen R. Effect of short-term treatment with regular or high doses of omeprazole on the detection of helicobacter pylori in bleeding peptic ulcer patients. Scand J Gastroenterol. 2003;38:588–593.PubMedCrossRef
9.
go back to reference Bromley M, Rew D, Becciolini A, et al. A comparison of proliferation markers (BrdUrd, ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Eur J Histochem. 1996;40:89–100.PubMed Bromley M, Rew D, Becciolini A, et al. A comparison of proliferation markers (BrdUrd, ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Eur J Histochem. 1996;40:89–100.PubMed
10.
go back to reference Azmi S, Dinda AK, Chopra P, Chattopadhyay TK, Singh N. Bcl-2 expression is correlated with low apoptotic index and associated with histopathological grading in esophageal squamous cell carcinomas. Tumour Biol. 2000;21:3–10.PubMedCrossRef Azmi S, Dinda AK, Chopra P, Chattopadhyay TK, Singh N. Bcl-2 expression is correlated with low apoptotic index and associated with histopathological grading in esophageal squamous cell carcinomas. Tumour Biol. 2000;21:3–10.PubMedCrossRef
11.
go back to reference Takeuchi K, Ukawa H, Furukawa O, et al. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice. J Physiol Pharmacol. 1999;50:155–167.PubMed Takeuchi K, Ukawa H, Furukawa O, et al. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice. J Physiol Pharmacol. 1999;50:155–167.PubMed
12.
go back to reference Itoh YH, Noguchi R. Pre-treatment with mild whole-body heating prevents gastric ulcer induced by restraint and water-immersion stress in rats. Int J Hyperth. 2000;16:183–191.CrossRef Itoh YH, Noguchi R. Pre-treatment with mild whole-body heating prevents gastric ulcer induced by restraint and water-immersion stress in rats. Int J Hyperth. 2000;16:183–191.CrossRef
13.
go back to reference Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res. 1998;83:117–132.PubMedCrossRef Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res. 1998;83:117–132.PubMedCrossRef
14.
go back to reference Udd M, Miettinen P, Palmu A, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scand J Gastroenterol. 2001;36:1332–1338.PubMedCrossRef Udd M, Miettinen P, Palmu A, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scand J Gastroenterol. 2001;36:1332–1338.PubMedCrossRef
15.
go back to reference Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394–397.PubMedCrossRef Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394–397.PubMedCrossRef
16.
17.
go back to reference Rantanen T, Honkanen T, Paavonen T, Rantanen L, Oksala N. Altered expression of HSP27 and HSP70 in distal oesophageal mucosa in patients with gastro-oesophageal reflux disease subjected to fundoplication. Eur J Surg Oncol. 2011;37:168–174.PubMedCrossRef Rantanen T, Honkanen T, Paavonen T, Rantanen L, Oksala N. Altered expression of HSP27 and HSP70 in distal oesophageal mucosa in patients with gastro-oesophageal reflux disease subjected to fundoplication. Eur J Surg Oncol. 2011;37:168–174.PubMedCrossRef
18.
go back to reference Liu J, Li ZS, Wan XJ, Wang W. Expression and function of apoptosis-related genes bcl-2/Bax and Fas/Fas L in the course of stress ulcer. Zhonghua Yi Xue Za Zhi.. 2003;83:504–509.PubMed Liu J, Li ZS, Wan XJ, Wang W. Expression and function of apoptosis-related genes bcl-2/Bax and Fas/Fas L in the course of stress ulcer. Zhonghua Yi Xue Za Zhi.. 2003;83:504–509.PubMed
19.
go back to reference Maity P, Bindu S, Choubey V, et al. Lansoparazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal. J Biol Chem. 2008;283:14391–14401.PubMedCrossRef Maity P, Bindu S, Choubey V, et al. Lansoparazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal. J Biol Chem. 2008;283:14391–14401.PubMedCrossRef
20.
go back to reference Maróstica M, Arcari D, Bartchewsky W Jr, et al. Effects of one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Scand J Gastroenterol. 2007;42:1404–1412.PubMedCrossRef Maróstica M, Arcari D, Bartchewsky W Jr, et al. Effects of one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Scand J Gastroenterol. 2007;42:1404–1412.PubMedCrossRef
21.
go back to reference Tarnawski AS, Ahluwalia A. Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and esophageal ulcers. Curr Med Chem. 2012;19:16–27.PubMedCrossRef Tarnawski AS, Ahluwalia A. Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and esophageal ulcers. Curr Med Chem. 2012;19:16–27.PubMedCrossRef
22.
go back to reference Chen CC, Lee JY, Fang YJ, et al. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. Aliment Pharmacol Ther. 2012;35:894–903.PubMedCrossRef Chen CC, Lee JY, Fang YJ, et al. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. Aliment Pharmacol Ther. 2012;35:894–903.PubMedCrossRef
23.
go back to reference Neumann I, Letelier LM, Rada G, et al. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Datab Syst Rev. 2013;6:007999. Neumann I, Letelier LM, Rada G, et al. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Datab Syst Rev. 2013;6:007999.
24.
go back to reference Peskar BM, Maricic N, Gretzera B, Schuligoi R, Schmassmann A. Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci. 2001;69:2993–3003.PubMedCrossRef Peskar BM, Maricic N, Gretzera B, Schuligoi R, Schmassmann A. Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci. 2001;69:2993–3003.PubMedCrossRef
25.
go back to reference Zinkievich JM, George S, Jha S, Nandi J, Levine RA. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats. Clin Exp Pharmacol Physiol. 2010;37:654–661.PubMedCrossRef Zinkievich JM, George S, Jha S, Nandi J, Levine RA. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats. Clin Exp Pharmacol Physiol. 2010;37:654–661.PubMedCrossRef
26.
go back to reference Hatazawa R, Tanaka A, Tanigami M et al. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am J Physiol Gastrointest Liver Physiol. 2007;293:G788–G797. Hatazawa R, Tanaka A, Tanigami M et al. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am J Physiol Gastrointest Liver Physiol. 2007;293:G788–G797.
27.
go back to reference Ebert MP, Schafer C, Chen J, et al. Protective role of heat shock protein 27 in gastric mucosal injury. J Pathol.. 2005;207:177–184.PubMedCrossRef Ebert MP, Schafer C, Chen J, et al. Protective role of heat shock protein 27 in gastric mucosal injury. J Pathol.. 2005;207:177–184.PubMedCrossRef
28.
29.
go back to reference Petersson F, Franzén L, Borch K. Characterization of the gastric cardia in volunteers from the general population. Type of mucosa, Helicobacter pylori infection, inflammation, mucosal proliferative activity, p53 and p21 expression, and relations to gastritis. Dig Dis Sci. 2010;55:46–53.PubMedCrossRef Petersson F, Franzén L, Borch K. Characterization of the gastric cardia in volunteers from the general population. Type of mucosa, Helicobacter pylori infection, inflammation, mucosal proliferative activity, p53 and p21 expression, and relations to gastritis. Dig Dis Sci. 2010;55:46–53.PubMedCrossRef
30.
go back to reference Xia H, Zhang G, Talley N, et al. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol. 2002;97:3023–3031.PubMedCrossRef Xia H, Zhang G, Talley N, et al. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol. 2002;97:3023–3031.PubMedCrossRef
31.
go back to reference Loogna P, Franzén L, Sipponen P, Domellöf L. Cyclooxygenase-2 and Bcö-2 expression in the stomach mucosa of Wistar rats exposed to Helicobacter pylori, N´-methyl-N´-nitro-N-nitrosoguanidine and bile. Virchows Arch. 2002;441:77–84.PubMedCrossRef Loogna P, Franzén L, Sipponen P, Domellöf L. Cyclooxygenase-2 and Bcö-2 expression in the stomach mucosa of Wistar rats exposed to Helicobacter pylori, N´-methyl-N´-nitro-N-nitrosoguanidine and bile. Virchows Arch. 2002;441:77–84.PubMedCrossRef
32.
go back to reference Stolte M, Eidt S, Ohnsmann A. Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Z Gastroenterol. 1990;28:229–233.PubMed Stolte M, Eidt S, Ohnsmann A. Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Z Gastroenterol. 1990;28:229–233.PubMed
Metadata
Title
Effect of Omeprazole Dose, Nonsteroidal Anti-inflammatory Agents, and Smoking on Repair Mechanisms in Acute Peptic Ulcer Bleeding
Authors
Tuomo Rantanen
Marianne Udd
Teemu Honkanen
Pekka Miettinen
Vesa Kärjä
Lassi Rantanen
Risto Julkunen
Harri Mustonen
Timo Paavonen
Niku Oksala
Publication date
01-11-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3242-z

Other articles of this Issue 11/2014

Digestive Diseases and Sciences 11/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine